Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03813667 · ClinicalTrials.gov registry record · NA

Palliative Care Coaching for Families With Rare Advanced Lung Diseases

A NA study of Lung Diseases and Rare Non-Neoplastic Disorder, sponsored by West Virginia University.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT03813667 is a NA study of Lung Diseases and Rare Non-Neoplastic Disorder that has completed, run by West Virginia University. The registered enrollment target is 35 participants, below the 738-participant average among 31 other Lung Diseases trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03813667, a NA study of Lung Diseases and Rare Non-Neoplastic Disorder, has completed, sponsored by West Virginia University.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

With one of the highest incidences of lung disease deaths in the nation, there is great need for home end-of-life palliative care in the rural, disadvantaged communities of West Virginia. The aims of this proposed study are to: (1) pilot test the nursing care intervention with patients and family members managing home supportive EOLPC for rare advanced lung disease and (2) collect research data to report in the NIH resubmission and future trials.

Interventions

  • BEHAVIORAL Intervention FamPALcare

Study Locations (1)

West Virginia

  • West Virginia University Hospital - Morgantown

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2018-11-01
Est. Completion 2019-09-30
Phase NA

Sponsor

West Virginia University

122 total trials

What the Registry Record Tells You About NCT03813667

The ClinicalTrials.gov registry entry for NCT03813667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 738-participant average among 31 other Lung Diseases trials with a reported enrollment target (95% lower). The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Diseases appearing as the primary indexed condition, and to 1 intervention - of which Intervention FamPALcare is the first listed.

NCT03813667 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.

Frequently Asked Questions

What is clinical trial NCT03813667 about?

NCT03813667 is a clinical study titled "Palliative Care Coaching for Families With Rare Advanced Lung Diseases". With one of the highest incidences of lung disease deaths in the nation, there is great need for home end-of-life palliative care in the rural, disadvantaged communities of West Virginia. The aims of this proposed study are to: (1) pilot test the nursing care intervention with patients and family me...

What is the current status of trial NCT03813667?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-11-01. Estimated completion is 2019-09-30.

What conditions does trial NCT03813667 study?

This clinical trial studies the following conditions: Lung Diseases, Rare Non-Neoplastic Disorder.

What interventions are being tested in trial NCT03813667?

The interventions under investigation include: Intervention FamPALcare (BEHAVIORAL).

Who is sponsoring clinical trial NCT03813667?

This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03813667 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.